---
title: "InSilico Medicine plans US$305 million convertible bond sale"
url: "https://aibio.space/news/insilico-medicine-plans-us-305-million-convertible-bond-sale/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-08-28"
section: "Debt Financing"
tickers: "HKEX:3696"
source: "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082800033.pdf"
summary: "The company agreed on August 27, 2026 to issue convertible bonds with an initial conversion price of HK$58.07 per share."
---

By the aibio.space news desk.

Sources

- [InSilico Medicine Cayman TopCo announcement (2026-08-28)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082800033.pdf)

[3696](https://aibio.space/companies/insilico-medicine-cayman-topco/)

2026-08-28

# InSilico Medicine plans US$305 million convertible bond sale

Tickers [3696](https://aibio.space/companies/insilico-medicine-cayman-topco/)

The company agreed on August 27, 2026 to issue convertible bonds with an initial conversion price of HK$58.07 per share.

## Key facts

- **Company**: InSilico Medicine Cayman TopCo (HKEX: 3696)

- **News type**: Debt Financing

- **Primary source**: [InSilico Medicine Cayman TopCo announcement (2026-08-28)](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082800033.pdf)

*A trading board being updated by hand. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

InSilico Medicine Cayman TopCo said that on August 27, 2026, after trading hours, it signed a subscription agreement to issue bonds in an aggregate principal amount of US$305,000,000. The Manager, Deutsche Bank AG, Hong Kong Branch, is sole global coordinator, sole lead manager and sole bookrunner. It agreed to subscribe for the bonds or procure subscribers to take them up, acting as underwriter. The bonds are zero coupon.

The bonds are convertible into shares at an initial conversion price of HK$58.07 per share, subject to adjustments. That price is a premium of approximately 23.5% over the closing price of HK$47.02 per share on August 27, 2026. It is also a premium of approximately 32.9% over the average closing price of HK$43.70 per share for the five consecutive trading days before the agreement.

If the bonds were fully converted at that price, they would convert into approximately 41,174,737 shares. The announcement puts that at about 7.07% of the issued share capital as at August 27, 2026, and about 6.60% of the share capital as enlarged by full conversion.

Gross proceeds are expected to be approximately US$305 million. After the Manager's commissions and other estimated expenses, net proceeds are estimated at approximately US$301.6 million. The announcement gives an estimated net issue price of about HK$57.42 per conversion share. The issue is made under the general mandate, and completion is subject to the conditions in the subscription agreement. Most net proceeds are earmarked for clinical trials and R&D.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

3696

InSilico Medicine Cayman TopCo

HKEX · Hong Kong

Open the starter desk

## More in Debt Financing

Debt Financing

### [Pelthos amends Horizon venture loan, funds Loans E to H and adds Loans I and J](https://aibio.space/news/pelthos-amends-horizon-venture-loan-funds-loans-e-h-adds-loans/)

Oct 30, 2026

Debt Financing

### [Repligen announces $1.0 billion private convertible notes transaction](https://aibio.space/news/repligen-announces-1-0-billion-private-convertible-notes-transaction/)

Oct 30, 2026

Debt Financing

### [FOXO to buy Ludwig Enterprises preferred stock with majority voting power](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/)

Oct 29, 2026

---
Source page: https://aibio.space/news/insilico-medicine-plans-us-305-million-convertible-bond-sale/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "InSilico Medicine plans US$305 million convertible bond sale", 2026-08-28, https://aibio.space/news/insilico-medicine-plans-us-305-million-convertible-bond-sale/